CAP-53194 is a potent and selective Plk1 inhibitor. References: Shino N, Uchida T, Yoshida M, Nomura Y. Development and Assessment of a Nomogram to Propose the Initial Dosage Regimen of a Meropenem Infusion Based on Serum Creatinine and Age Using a Monte Carlo Simulation. Chem Pharm Bull (Tokyo). 2015;63(12):986-91. doi: 10.1248/cpb.c15-00494. PubMed PMID: 26633021.

纯度：≥98%

CAS：660817-08-3